Levothyroxine Solution IV -Stability in IV Syringes

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org. 

4 posts / 0 new
Log in or register to post comments
Last post
Wed, 02/10/2021 - 16:36
#1
Marina Rabin
Marina Rabin's picture
Offline
Last seen: 6 months 1 week ago
Joined: 12/10/2018 - 13:49
Levothyroxine Solution IV -Stability in IV Syringes

Our hospital would like to begin using Fresenius Kabi's concentration based Levothyroxine IV solution product (20 mCG/mL, 5 mL),but we are having a hard time figuring out stability of patient specific syringe pulled in IV room in ISO 5.

Manufacturer does not give ANY stability information for when the dose is drawn up in a patient specific IV syringe(BD/Monoject). Anyone has any experience, with dispensing the product, that they can share?
Thank you.

Top